| Dabrafenib Mesylate(GSK-2118436B) |
达帕菲尼甲磺酸盐 |
1195768-06-9 |
| Sofosbuvir |
索非布韦 |
1190307-88-0 |
| RVX-208 |
RVX-208 |
1044870-39-4 |
| CAY10603 |
HDAC6 Inhibitor |
1045792-66-2 |
| MK-4827 (tosylate) |
(3S)-3-[4-[7-(氨基羰基)-2H-吲唑-2-基]苯基]哌啶对甲苯磺酸盐 |
1038915-73-9 |
| Trelagliptin succinate |
琥珀酸曲格列汀 |
1029877-94-8 |
| BMS-794833 |
BMS-794833 |
1174046-72-0 |
| LX-4211 |
索格列净 |
1018899-04-1 |
| VX-661 |
VX-661 |
1152311-62-0 |
| Avagacestat (BMS-708163) |
Avagacestat (BMS-708163) |
1146699-66-2 |
| CX-5461 |
CX-5461 |
1138549-36-6 |
| 6,8-Difluoro-4-pyridin-3-yl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline |
GOLGICIDEA |
1139889-93-2 |
| Cabozantinib Malate |
苹果酸卡博替尼 |
1140909-48-3 |
| N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine |
ASP3026 |
1097917-15-1 |
| LY-2584702 (tosylate salt) |
LY2584702 TOSYLATE |
1082949-68-5 |
| PARECOXIB SODIUM |
帕瑞昔布钠 |
198470-85-8 |
| Parecoxib |
帕瑞昔布 |
198470-84-7 |
| WYE-354 |
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯 |
1062169-56-5 |
| COTI-2 |
COTI-2 |
1039455-84-9 |
| AZD-4547 |
AZD-4547 |
1035270-39-3 |
